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ABSTRACT
Introduction: Self-harm is a strong predictor for
suicide. Risks for repeat behaviour are heightened in
the aftermath of an index episode. There is no
consensus on the most effective type of intervention to
reduce repetition. Treatment options for patients who
do not require secondary mental health services
include no support, discharge to general practitioner or
referral to primary care mental health support services.
The aim of this study is to assess whether it is feasible
to deliver a brief intervention after an episode and
whether this can reduce depressive symptoms and
increase the sense of well-being for patients who
self-harm.
Methods: This is a non-blinded parallel group
randomised clinical trial. 120 patients presenting with
self-harm and/or suicidal ideation to mental health
services over a 12-month period who are not referred
to secondary services will be randomised to either
intervention plus treatment as usual (TAU), or control
(TAU only). Patients are assessed at baseline, 4 and
12 weeks with standardised measures to collect data
on depression, well-being and service use. Primary
outcome is depression scores and secondary
outcomes are well-being scores and use of services.
The findings will indicate whether a rapid response
brief intervention is feasible and can reduce depression
and increase well-being among patients who self-harm
and do not require secondary services.
Ethics and dissemination: Ethical approval was
granted by the UK National Health Service (NHS) Ethics
Committee process (REC 6: 14/WA/0074). The findings
of the trial will be disseminated through presentations
to the participating Health Board and partners, peer-
reviewed journals and national and international
conferences.
Trial registration number: ISRCTN76914248;
Pre-results.
BACKGROUND
Self-harm is the strongest risk factor for
future suicide1 resulting in over 200 000 hos-
pital presentations annually in England and
Wales2 3 and is associated with high personal,
social and medical costs.4 Repetition is
common, with 15–25% re-presenting to the
same hospital within a year of the index
episode.5 The highest risk of repeat self-harm
is within 3–6 months after the index episode6
with the risk for suicide in the year following
self-harm almost 50 times higher than in the
general population.7
Depressive symptoms are prevalent among
those with self-harm and suicidal ideation8
and is strongly linked with progression to
attempt suicide.9 Owing to the strong link
between a mental health condition and self-
Strengths and limitations of this study
▪ The development of an enhanced contact inter-
vention for people who have little or no support
following self harm.
▪ A focus on social issues that are present in the
person’s life.
▪ A cost-effective intervention that can work along-
side existing services, supporting patients during
a vulnerable time and keeping them engaged
whilst they are awaiting assessment from other
services.
▪ As this is an unblinded trial, there is a risk of
bias in the data.
▪ We are not collecting any social outcome
measures.
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harm,10 the majority of interventions are based on psy-
chological and medical approaches.11 However, it is not
just mental health disorders that trigger self-harm, it is
known that most patients who present with self-harm
have numerous social and interpersonal problems which
act as catalysts for self-harm behaviour.12 13 Hence
National Institute for Health and Care Excellence
(NICE) guidelines explicitly state that patients who
present with self-harm should receive a psychosocial
assessment14 to address their psychological and social
needs. However, this is often not routinely offered15 and
many patients who present to the emergency depart-
ment with self-harm are discharged without any assess-
ment16 despite evidence that psychosocial assessment is
associated with a lower risk of repetition.17 Presentations
to hospital tend to prioritise risk factors to determine
medical needs, admission, referral or discharge, above
psychosocial needs. A lack of psychosocial assessment
leaves much of the impact of social situations underexa-
mined. While addressing immediate psychological and
medical needs are vital, a lack of exploration of the
social milieu of the patient may miss important factors
that might have been precipitous in the self-harm behav-
iour and therefore may be a recurring antecedent for
self-harm. In the absence of routine psychosocial assess-
ments,15 patients who present with self-harm and who
do not have a known history of mental health problems,
often receive little or no support from healthcare ser-
vices, with signposting to community services or dis-
charge to general practitioner (GP) being the main
course of management. Supporting such individuals
who do not require secondary mental health services to
deal with stressors and enabling them to better manage
stressors may help alleviate their impact and thus reduce
rates of self-harm as a response to ongoing or repeated
stress.
There have been calls to explore social factors when
assessing self-harm as they are increasingly being identiﬁed
as instrumental in these behaviours.18 Studies report that
as many as 70% of self-harm episodes are triggered by
interpersonal problems.19 The importance of recognising
and responding to social factors in self-harm and suicide
prevention has been described in the literature.20 There is
global evidence of signiﬁcant increases in suicide rates fol-
lowing economic recession21 with unemployment being
strongly linked with suicide for men and women.20
Research has also linked an elevated risk of suicide with
isolation and a lack of social integration.22
There is little effective primary care prevention for
patients who self-harm either as a ﬁrst episode or repeat-
edly.23 Numerous interventions have been trialled in
attempting to reduce self-harm and suicidal behav-
iour.24 25 These vary signiﬁcantly in content, and no
single type of intervention has been found to deliver
consistent results. Positive outcomes in reducing self-
harm have been reported for non-pharmacological
interventions26 such as provision of an emergency access
card.27 Findings from contact interventions vary, with
some reporting long-term positive impacts.28–31 Contact
interventions, including telephone, postcard and letter
interventions offer a cost-effective way of supporting indi-
viduals by reducing a sense of isolation and increasing a
sense of social connectedness; it has been argued that
perceived connectedness can reduce suicidal ideation.31
An elevated sense of support may encourage help
seeking at times of crisis.31 Reviews of contact-based
interventions (eg, postcards, crisis cards, telephone
calls) after admission to a hospital have found inconsist-
ent results across studies and concluded that more
research is needed.30 31
This study draws on ﬁndings that suggest increasing
social support through contact-based interventions can
support those who self-harm and reduce suicide rates.29
An Australian study32 reported an intervention focusing
on connecting individuals to relevant and available
support led to a reduction in depression scores and an
increase in well-being. This study adapts that interven-
tion to offer a brief non-psychological and non-medical
intervention delivered by trained practitioners. Initially,
we intended to replicate the study, but a difference in
healthcare systems and access across Australia and the
UK, means that a full replication is not possible (see
Willis et al33 for a description of the Australian health-
care system). In remaining as close to that study we are
using the same outcome measures they applied— Beck
Depression Inventory—II (BDI-II)34 to measure depres-
sion and Manchester Short Assessment of Quality Of
Life (MANSA)35 to measure quality of life. Additionally
we are collecting the Client Services Receipt Inventory
(CSRI)36 to measure service use and the study is regis-
tered with the Secure Anonymised Information Linkage
(SAIL) database for a 1-year follow-up of service
use.37 38
The aim of this study is to assess whether an enhanced
contact intervention is beneﬁcial for patients who
present with self-harm and/or suicidal ideation but are
not referred to secondary services. We deﬁne it as an
enhanced contact intervention as it goes further than
what is usually termed contact intervention in the litera-
ture. Contact interventions tend to be more remote and
use postcards or phonecalls.28–30 Our intervention
involves regular face-to-face contact. It focuses on social
factors and actively links individuals to services that can
help with social problems including ﬁnancial issues,
housing, relationship difﬁculties, employment, literacy,
etc. The intervention is ﬂexible to meet the needs of the
patient; it does not require patients to engage with ser-
vices if they are not ready; for such patients, regular
contact with the intervention practitioner provides
support and a source of social contact at a vulnerable
time. The intervention goes beyond signposting with
assertively linking the individual to relevant support
agencies (eg, community organisations) that already
exist. By doing so, the individual becomes embedded in
to a support network from which they can draw on at
future times of stress.
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METHODS
Design and setting
This is a randomised controlled trial (RCT) conducted
by Swansea University in partnership with Hywel Dda
University Health Board (HDUHB) running between
January 2015 and March 2016 in Carmarthenshire, West
Wales. The trial delivers an enhanced contact interven-
tion to patients over 18 who present to mental health
services (deﬁned as hospital emergency department and
local primary mental health support services) and who
would ordinarily be referred back to primary care and/
or community services. Patients who require admission
or crisis intervention are excluded from Social support
and Wellbeing Intervention following Self Harm
(SWISH) and referred to appropriate services. Patients
who meet the inclusion criteria are randomised to the
intervention or control group. The intervention is a 4–
6-week programme of face-to-face and phone call
contact tailored to meet the needs of the individual in
addition to treatment as usual (TAU) which ranges from
discharge with no further support, signposting via leaf-
lets to community organisations, or referral to primary
care for ongoing care. The control arm is just TAU. The
full duration of patient participation is 12 weeks with
assessments collecting standardised measures for depres-
sion, well-being and service use conducted for all
patients at baseline, 4 and 12 weeks. Where possible a
6-month follow-up using the same measures will be
sought (see ﬁgure 1).
Study population
Patients who present to mental health services
(either directly to hospital or indirectly through referral
from GP to local primary mental health support ser-
vices) with self-harm and/or suicidal ideation are
assessed by the mental health practitioners at these sites
and those thought suitable for SWISH are referred to
SWISH in addition to their TAU. A SWISH worker
conducts a further eligibility test based on inclusion
and exclusion criteria before inviting a patient who
meets the requirements to participate. Patients are
given a study information leaﬂet and time to consider
whether they would like to take part. Written consent is
obtained by the research assistant prior to baseline data
collection. Once baseline data have been collected
patients are randomly assigned to either intervention or
control.
Inclusion criteria
Any person aged 18 or over who presents to mental
health services with self-harm and/or suicidal ideation
and is assessed by a mental health practitioner at these
sites to not require secondary mental health services
and be suitable for SWISH.
Exclusion criteria
Anyone who following assessment by a mental health
practitioner meets at least one of the following criteria:
▸ Unable to give informed consent;
▸ Requires admission to a mental health inpatient unit;
▸ Requires secondary mental health services;
▸ Assessed as high risk for violence;
▸ Known or assessed to have a severe mental illness and
require other services;
▸ Is under a current and active care and treatment plan
with adult mental health services;
▸ Is unable to communicate in English.
At any point, if a recruited patient meets any of the
exclusion criteria they are withdrawn from the study, but
their anonymised data will be retained for analysis.
Power and sample size
The power analysis is based on the primary outcome
measure, BDI-II score. Based on published reviews and
papers, a 5–10% change in the BDI-II score represents a
clinically important difference and the SD varies
between 6 and 10,39–41 which provides an effect size of
∼0.53. To detect a 5–10-point difference in the BDI
mean score between intervention and the control condi-
tions, with 80% power, requires a sample size of 120 (60
in each arm of the trial).
As this study is assessing feasibility for a full trial of a
new intervention, we cannot anticipate the attrition rate,
but will use the attrition at 6 and 12 weeks to inform the
full trial. For the same reason there are no stopping
guidelines, except the complete failure to recruit to the
required sample size.
Randomisation
We performed an individual randomisation of the
patients from the study population who met the inclu-
sion criteria. As this is a feasibility study, we did not use
any stratiﬁcation for randomisation (eg, stratify between
ideators and self-harmers). We will be looking at differ-
ences during analysis, and should there be any signiﬁ-
cant differences we intend to incorporate stratiﬁcation
in the future full trial. Patients are randomised by the
intervention practitioner after completion of baseline
assessment using an online randomisation tool managed
by Swansea Trials Unit. Patients are randomised with a
ratio of 1:1 to intervention and control and used
random numbers generated from the New Cambridge
Statistical Table.42
Intervention
The intervention is a 4–6-week enhanced contact pro-
gramme which is a mix of face-to-face and telephone
contact. It deliberately steers away from being a psycho-
logical or medical service; rather it is based on linking
individuals into social support networks and encour-
aging access to, and engagement with, relevant services.
It is an additional rather than alternative service for
support services already in place, and encourages
patients to engage with existing services. As such, as long
as patients are not receiving support from secondary
mental health services (an exclusion criteria based on
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higher support needs of secondary mental health
service users); there is no contraindication to involve-
ment with SWISH.
An awareness of local third-sector services is key to the
role of the practitioner. The intervention can be deliv-
ered by a skilled individual who has experience of
working with people with mental health issues. The prac-
titioners delivering the intervention in this trial have
worked in mental health services but are not registered
mental health practitioners. They have experience of
working in Carmarthenshire within mental health ser-
vices and/or developing mental health services for vul-
nerable populations. By not requiring practitioners to
hold registrations, the intervention is more cost-effective
to deliver as it relies on locality-based training and aware-
ness above registration. A condition of employment is to
have enhanced disclosure and barring service clearance
before initiation. The practitioners receive training on
mental health service delivery in Carmarthenshire from
an advanced nurse practitioner in mental health services.
Formal clinical supervision with the advanced nurse prac-
titioner is once a fortnight or more depending on
requirements; the supervisor is available at all times on
the phone for immediate questions, and monitors the
delivery of the intervention and patient contact.
The intervention encourages individuals to link with
local services. In this trial some of the agencies patients
are linked into include Men’s Shed projects, adult edu-
cation courses, knitting groups and volunteering ser-
vices, as well as services supporting individuals with drug
and alcohol issues and domestic abuse. The choice of
service is decided alongside the patient based on the
type of support and engagement they would like. The
intervention primarily focuses on the social dimensions
of a person’s life; the medical and psychological needs
of the patient will have been assessed prior to the
patient’s referral to SWISH. If at any time during the
intervention the practitioner is concerned that these
needs may be escalating and require specialised support,
or there is a crisis situation this will be immediately dis-
cussed with the clinical supervisor who will refer the
patient accordingly; and SWISH will continue to support
the patient for the duration of the intervention, or until
they meet the exclusion criteria and are engaged with
relevant support services.
The ﬁrst patient–practitioner contact is as soon as pos-
sible after baseline has been collected by a research
assistant. At the ﬁrst meeting, the patient is encouraged
to discuss recent events and explore the reasons which
they feel led to their current situation. This meeting typ-
ically lasts about an hour. The practitioner works with
the patient to identify the main social issues they feel
precipitated this and discuss relevant agencies that may
be able to offer support and information. A plan of
action is then worked out with the patient where the
patient is given suggestions for services that they can
link in with. This plan is written up by the practitioner
and sent to the patient with information and contact
details for services.
TAU for patients with low or no mental health history
who present to the hospital emergency department is
usually a referral back to the GP, although some might be
signposted to services in the community usually by way of
leaﬂets provided. TAU for patients referred by their GP
to local primary mental health support services is an
assessment within 4–8 weeks and appropriate referral or
signposting. This intervention goes beyond signposting
to assertively link the patient with relevant services to
embed them within a supportive network at a time of
emergency and vulnerability to try and ameliorate the
negative impact of the self-harm episode. This ‘assertive
community linkage’ is the basis for the intervention. It
differs from signposting by actively encouraging patients
to contact relevant community agencies who can provide
specialised support and establish a supportive resource to
help manage future periods of stress. The practitioner
can follow-up whether they have made contact with any
agencies and explore reasons for reluctance to engage.
Where necessary, the practitioner can make a referral or
initiate contact and support for patients, for example,
one patient was keen to attend a local craft group but felt
scared to attend alone, the practitioner made contact
with the service and arranged for the patient to meet
with the craft group coordinator alone prior to attending
the group to discuss her fears and be reassured.
Figure 1 Study chart. GP, general practitioner; TAU,
treatment as usual.
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Follow-up contacts are a mix of face-to-face and tele-
phone contacts depending on agreement and discussion
with the patient. Patients are seen at a location that is
convenient to them, this includes home visits; however,
as part of the community linkage patients are encour-
aged to engage outside of the home and so meetings
are held in local spaces including GP surgeries, coffee
shops and arts centres. This is especially the case for
patients who do not feel conﬁdent or willing to actively
engage with available social networks or for whom there
is no local service that suits their needs. In such
instances, the practitioner provides a purely contact and
listening service, encouraging the patient to leave the
house and meet for a chat. Details of all contacts are
logged on the FACE electronic recording system used by
HDUHB as their healthcare notes recording system. The
number and nature (face-to-face or telephone) and
length of contacts vary depending on patient need and
are mutually decided between the patient and practi-
tioner. The minimum number is four and the maximum
is usually six, with the ﬁrst and ﬁnal contact always being
face to face. As this is a feasibility study we have been
ﬂexible with the ﬁnal number of sessions to accommo-
date patients who may be waiting for another service. In
this situation SWISH provides support until they are
engaged with another provider. This has resulted in up
to eight sessions in three cases.
This is an important feature of the intervention where
besides providing a stand-alone service linking indivi-
duals to community services it acts as a bridging service
for patients. Patients referred to local primary mental
health support services and those who have been
referred to other (non-secondary) mental health
support services such as psychological therapy services
typically face a 4–8-week wait for assessment. The inter-
vention provides a point of regular contact and support
during this waiting period.
Control
The control group receive TAU from the service they
presented to. This ranges from no action, discharge to
GP, signposting to community services and/or referral to
psychological therapy services. These treatments do not
conﬂict with SWISH.
Outcome measures
The primary outcome measure is the BDI-II, measuring
depressive symptoms as this was the primary outcome
measure in the Australian study. For the same reason
our secondary outcome assesses whether a social inter-
vention leads to overall increase in well-being, as mea-
sured by the MANSA. Additionally we are collecting data
on whether the intervention reduces rates of representa-
tion to mental health services as measured by the CSRI
and long-term follow-up of service use by SAIL.
Our choice of primary and secondary outcomes is
based on remaining as close to the Australian study as
possible based on the information available. For a
further trial, we will seek to collect data on social out-
comes, exploring the type and nature of social networks
that individuals engage with as an outcome of the
intervention.
Assessments
All patients complete assessments at baseline (before
randomisation), 4 and 12 weeks. Those who fall in to
the 6-month period while the study is running are
invited to complete a 6-month assessment. A 1-year
follow-up will be conducted by SAIL.
Baseline assessments
The baseline assessment consists of the BDI-II, MANSA
and CSRI. Patients are asked to complete these question-
naires as soon as possible after they consent. The ques-
tionnaires are designed to be self-completed, however
the researchers read out the questions and ﬁll in the
responses where requested by patients. Researchers note
whether they are required to read out any/all questions,
and any questions patients have asked for clarity or ela-
borated on while completing the questionnaire pack.
Patients are given a £10 voucher for their time after
completing the baseline assessment. All contact with
patients is recorded on the Health Board electronic
patient contact recording system.
Follow up assessments
Four-week follow-up
Follow-up assessments are conducted with the same
questionnaires (BDI-II, MANSA, CSRI) at 4 weeks.
Patients are given no incentive at the 4-week assessment.
Twelve-week follow-up
Patients are asked to complete the BDI-II, MANSA and
CSRI. Patients who complete the 12-week assessment are
given a £20 voucher for their time.
Additionally at the 12-week data collection patients are
asked to complete an evaluation form of their experi-
ence of SWISH. There is room for additional comments.
The researcher asks for the feedback on the contact and
this is recorded verbatim for qualitative analysis, and to
provide assessment of the service in the patient’s own
words. Initially, these data were only included for inter-
vention patients; however, we have begun to collect it for
control as well after control patients commented on the
support they felt they were receiving from the researcher
collecting assessment data.
Six-month follow-up
Early recruits are invited to take part in a 6-month
assessment where possible, and a further £10 voucher is
given for their time.
One-year follow-up
Patients have consented to being linked in anonymously
to the SAIL Databank (http://www.saildatabank.com/).
SAIL contains routinely collected anonymous data for
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Wales. We will use the SAIL data for the number of visits
(or contacts) to primary (GP) and secondary care (hos-
pital admission and emergency department visit) by the
SWISH patients for the year preceding and the year fol-
lowing the intervention. We will be collecting the counts
of contacts that relate to self-harm, suicidal ideation and
depression.
Blinding
There is no blinding of researchers or participants. The
information sheet clearly states the intervention is a 4–
6-week contact programme. The researcher advises all
patients that the intervention practitioner will be in
touch within a few days if they are randomised to the
intervention. It has proved impractical and almost
impossible to blind the researcher conducting the assess-
ments as at the week 4 assessment, there is often a clash
with intervention meetings for the patient. It would be
preferable for all assessments to be collected by the
researcher; however, due to stafﬁng issues in this trial
and to minimise the time commitment on the part of
the patient and maximise data collection, intervention
patients are given the option to complete the 4-week
assessment at an intervention meeting with the practi-
tioner rather than the researcher. Some intervention
patients prefer just to have one SWISH contact at the
4-week stage rather than ﬁnd time for separate meetings
with practitioner and researcher. The intervention
always includes a discussion of how they are feeling and
their social connectedness, so the administration of the
questionnaire at the time of intervention avoids some
repetition on the part of the patient where the question-
naire is being read to them. However, the majority of
questionnaires are completed by respondents individu-
ally and put into an envelope after completion, so the
practitioner is unaware of their responses. We acknow-
ledge that this might introduce some bias into the meth-
odology; but for a feasibility study and due to the
reasons outlined above, we feel that maximum data
return should be prioritised.
Trial management group
A trial management group, whose members include
study the applicants (academics and Health Board prac-
titioners), service users and representatives of commu-
nity organisations meets once a quarter to monitor
progress and discuss any issues arising. The chief investi-
gator also attends a monthly trial managers meeting at
the Swansea Trials Unit to update on progress and
discuss the project.
Analysis
Statistical analysis
Our analysis will be based on the primary and secondary
outcome measures which are the BDI-II score and
MANSA and CSRI. The hypothesis of interest is that the
change scores on these outcome measures will be signiﬁ-
cantly different in the intervention group compared
with the control group. We will analyse changes in all
outcome measures between baseline and follow-up at 4,
12 weeks and (where collected) 6 months by adopting
repeated measures analysis of variance. We shall use the
pertaining values of the outcome measure under ana-
lysis and consider participants’ demographic character-
istics (eg, age, marital status, sex education level) as
covariates. Since both the BDI-II score and MANSA are
well validated and use outcome measures, respectively,
for depression and ‘quality of life’, they do not require
checking of internal consistency.
As described above, we will be using SAIL to compare
the number of contacts to primary and secondary care
made by the SWISH participants before and after the
intervention between the case and control group. We
will use t-tests to assess any differences between the
groups.
We will adopt the intention-to-treat population, con-
sisting of all participants randomly assigned to the inter-
vention and control. To deal with the missing values, we
shall summarise the frequency of missing data for each
variable, which affects the effective sample size and
hence statistical power. If there is no reason to suspect
that data are not missing completely at random, we shall
consider the use of appropriate imputation methods to
ameliorate the problem of missing data; otherwise, the
trial statistician and chief investigator will further discuss
the patterns in missing data. Outcome descriptions, sum-
maries and comparisons will be expressed in accordance
with appropriate CONSORT guidelines,43 including esti-
mates with 95% CIs to summarise two-tailed tests at the
5% signiﬁcance level.
Health economics
Health service resource use in primary care, secondary
care and the community is collected using the CSRI
from participants in both arms of the trial at baseline, 4,
12 weeks and 6 months. Questions will relate to all
health service contacts (hospital appointments, hospital
stays, GP contacts, visiting nurse appointments, etc) and
prescription medicines dispensed during the trial
period. Patient recall has been shown to be a valid
method for collecting health service resource use data
over this period (and, as clinical records are often frag-
mented, and sometimes unavailable, across different
parts of the health service) patient-reported data are
likely to remain more readily available and less costly to
collect for research purposes.44 A descriptive analysis of
CSRI data, along with estimates of the cost of providing
the intervention, will provide a comparison of partici-
pant resource use between the intervention and control
groups, and will provide indicators of the main resource
use (and associated costs) drivers of those receiving the
intervention.
The CSRI data will be summarised and presented
descriptively. The resources used and associated costs
will be summarised. The costs of the intervention will be
estimated. These data will be used to compare the costs
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of the intervention and usual care and to inform the cal-
culation of incremental costs. The sources of costs will
be fully referenced to aid transparency of the analysis.
Where possible, published unit costs will be used (eg,
Personal Social Services Research Unit (PPRU) Costs of
Health and Social Care, British National Formulary,
National Health Service (NHS) reference costs) using
the most recent published sources—2014/2015. Costs
(mean and SD and/or 95% CIs) or non-parametric
equivalent (median and IQRs) will be presented.
Dissemination
Findings will be fed back to the Health Board and to
the third sector through presentations and contributions
in local publications. Outcomes will be published in
peer-reviewed journals and at national and international
conferences.
DISCUSSION
This paper describes the study protocol for a feasibility
study for a RCT of an enhanced contact intervention for
people who present with self-harm or suicidal ideation
and do not require secondary mental health services.
Several limitations apply to this study. First, interven-
tions tend to have a high attrition rate. Dropout can intro-
duce a selection bias and pose a threat to validity.
However, we are able to report a high rate of recruitment
at 100% of our target and successful intervention comple-
tion at 77% across the whole sample. If those who were
withdrawn from the study (due to meeting exclusion cri-
teria) are excluded, the completion rate for all those eli-
gible to complete the intervention rises to 83%.
Second, the services that SWISH is able to provide are
limited. Encouraging social linkage is largely dependent
on the availability of relevant options for individuals. In
a large, predominantly rural county,45 there are limited
choices, which are further reduced if there is no access
to transport. A social linkage programme will be able to
offer more resources in areas where there are more
agencies and community services to engage with. The
location and accessibility of services may affect the gen-
eralisability of ﬁndings to urban populations.
Third, while the assessments are intended to be self-
completed, a lack of conﬁdence on the part of patients
in completing questionnaires themselves meant that a
substantial number were read out by the researcher.
This may have affected responses.
Finally, as discussed above, the study was conducted
unblinded. Attempts were made to blind the researcher
collecting assessments, however, this was not practical.
However, even with limitations, the ﬁndings will offer an
insight into the applicability of a social intervention to be
alongside medical and psychological interventions.
SWISH offers a short-term crisis response to engage
patients while they are waiting for referrals to medical and
community services. Often there are 4–8-week waiting lists
to be seen by other services. SWISH ﬁlls this void and at
the very least it offers a contact and listening service to
individuals at a vulnerable time. By engaging with patients
while they are waiting for other appointments it can help
reduce rates not attending appointments with other
health and social care services by encouraging attendance.
Through embedding patients in to existing local organisa-
tions and services, SWISH helps to provide a source of
support for future stressful times.
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